Key result
Multidimensional HF disease management is linked to ~35% lower 1-year mortality versus standard care.
Why the study?
Does a multidisciplinary disease management programme reduce 1-year all-cause mortality in patients hospitalized for acute heart failure?
Cohort (n=1,816)
Yes
Does a multidisciplinary disease management programme reduce 1-year all-cause mortality in patients hospitalized for acute heart failure?
Hazard Ratio: 0.65 (95% CI 0.46–0.92)
Absolute Event Rate: 17.9% vs 21.3%
A multidisciplinary disease management program implemented after discharge for acute heart failure is associated with significantly reduced 1-year all-cause mortality.
DMP enrollment was associated with lower 1-year mortality after acute HF; leaves open whether structured programs improve survival in routine care.
We performed a multicenter prospective observational cohort study (Epidémiologie et Pronostic de l'Insuffisance Cardiaque Aiguë en Lorraine, Epidemiology and Prognosis of Acute Heart Failure in Lorraine [EPICAL2]) to evaluate the effectiveness on mortality of a community-based multidisciplinary disease management programme (DMP) for heart failure (HF) patients.Between October 2011 and October 2012, 1816 patients, who were hospitalized for acute HF or who developed acute HF during a hospitalization, were included from 21 hospitals in a northeast region of France. At hospital admission, their mean age was 77.3 (standard deviation [SD] 11.6) years and mean left ventricular ejection fraction was 45.0 (SD 16.0)%. A subset of patients were enrolled in a multidimensional DMP for HF (n = 312, 17.2%), based on structured patient education, home monitoring visits by HF-trained nurses, and automatic alerts triggered by significant clinical and biological changes to the patient. The DMP involved general practitioners, nurses, and cardiologists collaborating via an individual web-based medical electronic record. The outcome was all-cause mortality from the 3rd to the 12th month after discharge. During the follow-up, a total of 377 (20.8%) patients died: 321 (21.3%) in the control group and 56 (17.9%) in the DMP group. In a propensity score analysis, DMP was associated with lower 1-year all-cause mortality (hazard ratio 0.65, 95% CI 0.46-0.92). Instrumental variable analysis gave similar results (hazard ratio 0.56, 0.27-1.16).In a real world setting, a multidimensional DMP for HF with structured patient education, home nurse monitoring, and appropriate physician alerts may improve survival when implemented after discharge from hospitalization due to worsening HF.
No takes yet. Share an insight, caveat, or question.
Laborde‐Castérot et al. (2016) conducted a cohort in acute heart failure (n=1,816). multidimensional disease management programme vs. control group was evaluated on all-cause mortality from the 3rd to the 12th month after discharge (HR 0.65, 95% CI 0.46-0.92). A multidimensional disease management programme for heart failure was associated with lower 1-year all-cause mortality compared to standard care (17.9% vs 21.3%; HR 0.65, 95% CI 0.46-0.92).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: